BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 25, 2002
View Archived Issues
Chiron Reports Strong Earnings, Cuts Three Late-Stage Programs
Chiron Corp. reported robust third-quarter earnings, topping the Street's estimate by 14 cents per share, but also said it was dropping three late-stage programs, leaving some questioning the depth of its pipeline. (BioWorld Today)
Read More
OSI Drops Diabetes Program, Puts Full Focus On Oncology
Read More
Estren, Novel Hormone Substitute, Obviates Menopausal Bone, Breast Cancer Adversities - So Far In Mice
Read More
Amylin Pulls Symlin Filing In Europe; Problem Not Identified
Read More
Other News To Note
Read More
Vertex Expects Regulatory Filing For HIV Drug On Phase III Data
Read More
Appointments And Advancements
Read More
